Source – Pregabalin prescribing patterns in Australian general practice, 2012–2018: a cross-sectional study[/caption]
National Medicines Symposium 2024 speakers (L to R): Steve Waller, Professor Jennifer Martin, Professor Libby Roughead, Tegan Taylor[/caption]
This CPD activity is sponsored by Reckitt. All content is the true, accurate and independent opinion of the speakers and the views expressed are entirely their own.[/caption]
Opioid replacement therapy – supporting treatment
Drug dependence, including opioid dependence, involves a complex interplay of social, psychological and biological factors.
Learning objectives
After reading this article, pharmacists should be able...
Myths around asthma remain strong, new research finds
Fewer than half of all Australians can correctly identify asthma as a chronic disease that doesn’t go away, according to new Asthma Australia research.¹
In...
Choosing wisely: sedatives
In the third of a six-part series, we expand on the PSA Choosing Wisely recommendations, taking a closer look at the use of sedatives....
Choosing wisely to achieve medicine safety
The quality use of medicines is vital to ensure a sustainable healthcare system and better health outcomes for consumers.
This was the dominant theme at...
Rethinking how we manage osteoarthritis pain
Alex Page, pharmacist at Outback Pharmacies and former winner of the PSA Award for QUM in Pain Management, and Joyce McSwan, Founder and Managing...
Call for pharmacist access to the MBS for Chronic Disease Management
Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense.
After a...
